MedTrace Logo

HIPEC in Ovarian Cancer, Case-Controls Study With 10-years Follow up

NCT04234243 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 144

Last updated 2020-01-29

No results posted yet for this study

Summary

Objectives:

Compare overall survival (OS) and progression-free survival (PFS) among ovarian cancer patients who underwent into cytoreduction and HIPEC procedure vs patients who only received systemic chemotherapy in a 10-years follow up of a case-control study

Methods:

Cases were defined as patients treated by cytoreduction and HIPEC, and were matched (1:2) with patients treated with chemotherapy only, defined as controls. PFS and OS in the two groups were measured and compared. PFS was calculated from initiation of treatment to progression, death or to the last known follow-up. OS was calculated from initiation of treatment to death or to the last known follow-up.

Conditions

Interventions

PROCEDURE

cytoreduction and HIPEC

cytoreduction CCR 0-1, and HIPEC close technique

Sponsors & Collaborators

  • Instituto de Seguridad Social del Estado de Mexico y Municipios

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Max Age
72 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-01
Primary Completion
2017-12-31
Completion
2019-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04234243 on ClinicalTrials.gov